Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation

scientific article

Plasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.AB.2004.10.052
P698PubMed publication ID15745750

P2093author name stringDaniel R Wagner
Céline Jeanty
Didier Rouy
Isabelle Ernens
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)294-298
P577publication date2005-03-01
P1433published inAnalytical BiochemistryQ485215
P1476titlePlasma storage at -80 degrees C does not protect matrix metalloproteinase-9 from degradation
P478volume338

Reverse relations

cites work (P2860)
Q36789976Adsorbing/dissolving Lyoprotectant Matrix Technology for Non-cryogenic Storage of Archival Human Sera
Q36919974Banking of biological fluids for studies of disease-associated protein biomarkers
Q33809526Biomarkers of extracellular matrix metabolism (MMP-9 and TIMP-1) and risk of stroke, myocardial infarction, and cause-specific mortality: cohort study
Q33323378Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population
Q57120122Circulating matrix metalloproteinases and their tissue inhibitors as markers for ethnic variation in pelvic floor tissue integrity
Q37153161Circulating matrix metalloproteinases in children with diabetic ketoacidosis
Q98891633Compared DNA and RNA quality of breast cancer biobanking samples after long-term storage protocols in - 80 °C and liquid nitrogen
Q48516263DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex
Q34635975Effects of preanalytic variables on circulating microRNAs in whole blood
Q47115483Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne.
Q38063697Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group
Q34473927Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor
Q51629440Impact of cryopreservation on serum concentration of matrix metalloproteinases (MMP)-7, TIMP-1, vascular growth factors (VEGF) and VEGF-R2 in Biobank samples.
Q27001736Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis
Q38398370Isothermal vitrification methodology development for non-cryogenic storage of archival human sera.
Q49118867Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.
Q41324589Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds
Q50776557Matrix metalloprotease-2 and -9 concentration and activity in serum and culture medium samples: a methodological reappraisal.
Q38173695Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in the tumors of central nervous system (CNS).
Q37412311Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer
Q30433587Nitrogen biobank for cardiovascular research
Q35781795Plasma Matrix Metalloproteinase-9 Levels Predict First-Time Coronary Heart Disease: An 8-Year Follow-Up of a Community-Based Middle Aged Population
Q44511702Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals
Q36858663Pre-analytical stability of the plasma proteomes based on the storage temperature
Q60570652Reappraisal of Quantitative Gel Zymography for Matrix Metalloproteinases
Q34222299Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality
Q47960038Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study
Q37824829Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview
Q30925905Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study
Q40097601Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships
Q54972156Stability of matrix metalloproteinase-9 as biological marker in colorectal cancer.
Q41695234Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy.
Q42617736The Sample Type used Affects the Levels of Gelatinases (MMP-2 and -9) and their Inhibitors (TIMP-1 and -2) in Circulating Blood of Healthy Controls and Breast Cancer Patients

Search more.